Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study. - Michelson,D.; Faries,D.; Wernicke,J.; Kelsey,D.; Kendrick,K.; Sallee,R.; Spencer,T. (Pediatrics, 2001)